These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 32912226)

  • 21. Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis.
    Henry BM; Vikse J; Benoit S; Favaloro EJ; Lippi G
    Clin Chim Acta; 2020 Aug; 507():167-173. PubMed ID: 32348783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurobiology of coronaviruses: Potential relevance for COVID-19.
    Cataldi M; Pignataro G; Taglialatela M
    Neurobiol Dis; 2020 Sep; 143():105007. PubMed ID: 32622086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurological manifestations of COVID-19, SARS and MERS.
    Verstrepen K; Baisier L; De Cauwer H
    Acta Neurol Belg; 2020 Oct; 120(5):1051-1060. PubMed ID: 32562214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding the Immunologic Characteristics of Neurologic Manifestations of SARS-CoV-2 and Potential Immunological Mechanisms.
    Mohammadi S; Moosaie F; Aarabi MH
    Mol Neurobiol; 2020 Dec; 57(12):5263-5275. PubMed ID: 32869183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurological manifestations in COVID-19 caused by SARS-CoV-2.
    Baig AM
    CNS Neurosci Ther; 2020 May; 26(5):499-501. PubMed ID: 32266761
    [No Abstract]   [Full Text] [Related]  

  • 26. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
    Zhou Z; Kang H; Li S; Zhao X
    J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurological manifestations of COVID-19: a review of what we know so far.
    Gklinos P
    J Neurol; 2020 Sep; 267(9):2485-2489. PubMed ID: 32458197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 pandemic, coronaviruses, and diabetes mellitus.
    Muniyappa R; Gubbi S
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E736-E741. PubMed ID: 32228322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin-converting enzyme 2 (ACE2): COVID 19 gate way to multiple organ failure syndromes.
    Loganathan S; Kuppusamy M; Wankhar W; Gurugubelli KR; Mahadevappa VH; Lepcha L; Choudhary AK
    Respir Physiol Neurobiol; 2021 Jan; 283():103548. PubMed ID: 32956843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The trinity of COVID-19: immunity, inflammation and intervention.
    Tay MZ; Poh CM; Rénia L; MacAry PA; Ng LFP
    Nat Rev Immunol; 2020 Jun; 20(6):363-374. PubMed ID: 32346093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary Edema in COVID19-A Neural Hypothesis.
    U R A; Verma K
    ACS Chem Neurosci; 2020 Jul; 11(14):2048-2050. PubMed ID: 32614178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The involvement of the central nervous system in patients with COVID-19.
    Saleki K; Banazadeh M; Saghazadeh A; Rezaei N
    Rev Neurosci; 2020 May; 31(4):453-456. PubMed ID: 32463395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurological complications in a predominantly African American sample of COVID-19 predict worse outcomes during hospitalization.
    Chachkhiani D; Soliman MY; Barua D; Isakadze M; Villemarette-Pittman NR; Devier DJ; Lovera JF
    Clin Neurol Neurosurg; 2020 Oct; 197():106173. PubMed ID: 32877769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Environmental Issues and Neurological Manifestations Associated with COVID-19 Pandemic: New Aspects of the Disease?
    Bellocchio L; Bordea IR; Ballini A; Lorusso F; Hazballa D; Isacco CG; Malcangi G; Inchingolo AD; Dipalma G; Inchingolo F; Piscitelli P; Logroscino G; Miani A
    Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33139595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV.
    Singh A; Singh RS; Sarma P; Batra G; Joshi R; Kaur H; Sharma AR; Prakash A; Medhi B
    Virol Sin; 2020 Jun; 35(3):290-304. PubMed ID: 32607866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 Infection Leads to Neurological Dysfunction.
    Acharya A; Kevadiya BD; Gendelman HE; Byrareddy SN
    J Neuroimmune Pharmacol; 2020 Jun; 15(2):167-173. PubMed ID: 32447746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
    Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
    Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver injury during highly pathogenic human coronavirus infections.
    Xu L; Liu J; Lu M; Yang D; Zheng X
    Liver Int; 2020 May; 40(5):998-1004. PubMed ID: 32170806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.
    Zubair AS; McAlpine LS; Gardin T; Farhadian S; Kuruvilla DE; Spudich S
    JAMA Neurol; 2020 Aug; 77(8):1018-1027. PubMed ID: 32469387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis.
    Quan C; Li C; Ma H; Li Y; Zhang H
    Clin Microbiol Rev; 2020 Oct; 34(1):. PubMed ID: 33055229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.